Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells

Go back to Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
(NASDAQ: AUTL) Delayed: 2.40 +0.33 (15.94%)
Previous Close $2.07    52 Week High
Open $2.04    52 Week Low
Day High $2.43    P/E N/A 
Day Low $2.02    EPS
Volume 5,545,174